AUG 19, 2007 | Hillary on Health Care | THE AMERICAN PRESIDENCY PROJECT

Hillary introduced legislation – now enacted into law – which ensures prescription drugs are safe for children: As First Lady and Senator, Clinton successfully introduced and helped pass legislation protecting kids from drugs that have not first been tested on children. In 2003, Clinton introduced the Pediatric Research Equity Act which gave the FDA authority to secure pediatric studies and labeling of drugs that are widely used for children. This legislation was signed into law in December 2003. In 2007, she introduced the Pediatric Research Improvement Act to make “make permanent the Food and Drug Administration’s authority to ensure that drugs marketed for pediatric use are safe and effective for children.” [S.650, introduced 3/18/03, passed Senate by unanimous consent on 7/23/03, became P.L. 108-155 on 12/3/03. AP 11/19/03; Clinton release 3/27/07 ]

Hillary fought to ensure all children receive critical immunizations: Clinton spearheaded the Administration’s 1993 Childhood Immunization Initiative and childhood immunizations rates are now at an historic high. According to the Center for Disease Control (CDC), 90 percent or more of America’s toddlers received the most critical doses of each of the routinely recommended vaccines in 1996, 1997, and again in 1998 -surpassing the Administration’s 1993 goal. Since becoming a Senator in 2001, Clinton has introduced or cosponsored over 10 pieces of legislation to promote immunization awareness and provide for emergency vaccine supplies. [U.S. Newswire, 7/23/97; S. 371, S. 226]

As First Lady and Senator, Clinton successfully introduced and helped pass legislation protecting kids from drugs that have not first been tested on children. In 2003, Clinton introduced the Pediatric Research Equity Act which gave the FDA authority to secure pediatric studies and labeling of drugs that are widely used for children.

Now, by law, they must test on children.

CLINTON FOUNDATION DONORS | WASHINGTON POST | MAR 18, 2015

Including, but not limited to:

Pfizer Inc $1,000,001 – $5,000,000

Merck & Co., Inc. $250,001 – $500,000

Ranbaxy Pharmaceuticals Inc. $100,001 – $250,000

Johnson & Johnson $100,001 – $250,000

Sanofi-Aventis $100,001 – $250,000

Gilead Sciences, Inc. $100,001 – $250,000

The United States Pharmacopeial Convention (USP) $100,001 – $250,000

Novo Nordisk A/S $50,001 – $100,000

Novozymes A/S $50,001 – $100,000

AstraZeneca Pharmaceuticals LP $50,001 – $100,000

CL BioPharma Group $50,001 – $100,000

Novartis Group International AG $25,001 – $50,000

Napo Pharmaceuticals $10,001 – $25,000

Pharmaceutical Product Development, Inc. (PPD) $10,001 – $25,000

PharmaLinkFHI $10,001 – $25,000

Teva Pharmaceuticals Industries Ltd. $10,001 – $25,000

Genentech, Inc. $10,001 – $25,000

EMD Serono, Inc. $10,001 – $25,000

Genzyme Corporation $10,001 – $25,000

Eli Lilly and Company $25,001 – $50,000

Harold Snyder $1,000,001 – $5,000,000

Beryl Snyder $500,001 – $1,000,000

Brian S. Snyder $500,001 – $1,000,000

Jay Snyder $500,001 – $1,000,000

The Beatrice Snyder Foundation $100,001 – $250,000

Brian and Lavinia Snyder Foundation $50,001 – $100,000

Including, but not limited to:

Bill & Melinda Gates Foundation $25,000,000 or more

UK Department for International Development (DFID) $25,000,000 or more

Norwegian Ministry of Foreign Affairs $25,000,000 or more

The Australian Government $25,000,000 or more

UNITAID $25,000,000 or more

Children’s Investment Fund Foundation $10,000,000 – $25,000,000

Swedish International Development Cooperation Agency $10,000,000 – $25,000,000

Bill, Hillary & Chelsea Clinton Foundation $5,000,001 – $10,000,000

Centers for Disease Control and Prevention (CDC) $5,000,001 – $10,000,000

Africa Agriculture Development Company $1,000,001 – $5,000,000

African Institute of Biomedical Science and Technology $100,000 – $1,000,000

The past 20 years have seen a considerable shift in the location of clinical drug trials sponsored by transnational pharmaceutical companies (TNCs), with a signifcant expansion of such tests being conducted in low- and middle-income settings. This increased offshoring may result in serious ethical violations as highlighted by several recent field investigations and media reports.

An attractive research infrastructure, a fast-growing and largely treatment-naïve population, and lower costs make Egypt among the most popular places in the Middle East and Northern Africa (MENA) region for offshoring medicine testing. Egypt is second only to South Africa on the African continent in terms of the number of TNC-sponsored clinical trials it hosts.

Egypt in February 2016, over half were cancer trials. The two Swiss giants Novartis and Roche are responsible for almost 50 per cent of the international drug trials taking place in the country. The Arab spring events of early 2011 and the subsequent political unrest had no chilling effect on the number of active international drug trials – on the contrary.

South Africa is simply being exploited by the international drug companies to boost patient numbers and that the trials provide no long-term benefit for either the patients or local research staff.

Over the past decade (2003-2013), South Africa has become an important destination for many international pharmaceutical companies looking to carry out clinical trials. According to the online registry ClinicalTrials(.)gov, in February 2013, over 1,600 clinical trials had been registered in South Africa.

The country’s public health system is still predominantly used by the country’s impoverished black population and is in a serious state of decline. Despite progress in formulating new laws guaranteeing equal access to quality healthcare, shortages in medicines, doctors and hospital beds today remain the rule rather than the exception.

Widespread corruption also contributes significantly to the stark inequalities in the country’s health service. Certain amounts of health expenditure are believed to be lost through corruption as officials siphon off public money, and bribes and kickbacks are accepted from potential suppliers for coveted medicines and equipment contracts. According to health experts such as Professors Ames Dhai and Yousaf Veriava from the University of the Witwatersrand, “Corruption is a major and unambiguous contributor to the poor health of South African citizens.

Given the flaws and chronic problems which plague South Africa’s public health system, many people in the poorest communities often don’t have access to adequate or affordable healthcare. This means that the opportunity to take part in clinical trials is often seen by the most vulnerable as a way to get free treatment. And drug companies are quick to exploit this opportunity. “(Clinical trials) give people access to medicines that are not available in public hospitals. People are attracted to the fact the clinical trial will fund expensive medicines and medical assessment,” explains Professor Dhai. “The misconception among many vulnerable South Africans is very sad, because they feel the only chance of getting access to healthcare they need is to enter a clinical trial.

Fwd: Africa Trip/NYT Story | WIKILEAKS_PODESTA_47421 | AUG 27, 2012

From:matt.mckenna@gmail.com

To: john.podesta@gmail.com

CC: esanders@americanprogress.org

Date: 2012-08-27 20:11

Subject: Fwd: Africa Trip/NYT Story

Amy’s story, as I think I told you, is about the Foundation as a family business.

I would encourage you not to make any news on HRC coming back to the Foundation, running for President, etc. etc., but you already knew that.

As much as you can talk about all three of them having a lifelong commitment to public service and that something you’ve seen first hand for 20 years, etc., I think you’ll be in a good place.

Please let me know how you’d like me to handle connecting you with Amy.

Clinton Foundation in Africa: Delegation Briefing 2012 (PDF) | CLINTON FOUNDATION | 2012

President Clinton made his frst trip to Africa in 1998 – the longest, most extensive trip made to the continent by an American president. During this trip, he launched a number of initiatives aimed at education, economic empowerment, and peace and reconciliation. He forgave debt so nations could reinvest in health care, education, and poverty alleviation. He increased funding and research for lifesaving vaccines. And he signed the African Growth and Opportunity Act (AGOA) into law, which helped strengthen economic ties between the United States and Africa.

President Clinton has continued to build upon his longstanding commitment to Africa through the work of his Foundation, and has traveled through Africa many times since leaving the White House in 2001. Today, the Clinton Foundation’s programs in Africa are enabling sustainable development for families and communities; strengthening health systems and expanding access to lifesaving treatments for HIV/AIDS and malaria; Trough the Clinton Global Initiative, President Clinton has also advanced innovative partnerships between the public and private sector that have brought new investment and opportunity to the continent.

CGI members have made 138 commitments that include South Africa in their geographic scope, with an estimated total value of $4.2 billion. Te largest portion of these (39.9%) represents commitments in the feld of Economic Empowerment, and the largest specific area of focus is youth (39 commitments). Of these 138 commitments, 30 target South Africa exclusively, with an estimated total value of $197 million.

CHAI first began working in South Africa in 2003, when the government asked for assistance to develop a plan to significantly scale up HIV services and access to antiretroviral therapy

CHAI team members are embedded at the Department of Health and National Health Laboratory Service (NHLS) to provide support at multiple levels – policy formulation, implementation planning, and monitoring and oversight of implementation.

Prior to 2011, South Africa was purchasing HIV drugs above internationally competitive prices. CHAI helped achieve a 53% price reduction for ARVs, allowing the NDOH to realize an estimated savings of $700 million over two years, and putting hundreds of thousands of additional patients on life-saving treatment.

STRENGTHENING DIAGNOSTIC SERVICES

CHAI has been supporting the NDOH and the National Health Laboratory Service (NHLS) to scale up HIV and TB diagnostic services.

FUTURE PLANS: 2012 AND BEYOND

CHAI is proud of the role it has played over the past nine years in South Africa, and the NDOH’s leadership continues to foster an environment in which CHAI can work efficiently and effectively with all who have rallied to support the government’s efforts. CHAI will continue to support the NDOH scale up testing and treatment for HIV and TB at the national and provincial level. This work, in addition to eliminating malaria and increasing effectiveness of health spending, will be central to strengthening South Africa’s health system to combat—and eradicate—the HIV epidemic in the future.

Working in partnership with local communities and hospitals and international agencies such as UNICEF, UNITAID, the Clinton Health Access Initiative, Inc., AmpliCare is building and equipping laboratories, training healthcare workers, and diagnosing and monitoring HIV/AIDS patients.

Strengthening healthcare infrastructure: Investing in local capabilities

Functional healthcare systems, availability of facilities and trained healthcare professionals are critical for the effective use of tests and medicines and delivery of quality care. Lack of any one of these components can prevent people from being able to access medicines and diagnostics, particularly in some of the world’s poorest countries.

To help overcome these barriers, Roche has established a number of programmes aimed at making lasting improvement in healthcare systems. These range from educating and training healthcare professionals and regulatory personnel, to investing in clinics and laboratories and strengthening local manufacturing facilities and supply chains. Our focus is on increasing local capabilities, as we believe this provides the most sustainable way of addressing local health needs and helping develop healthcare systems for the future.

Strengthening diagnostic capabilities in Africa

One of the greatest healthcare challenges for Africa is not developing diagnostic tools or providing treatments, but is in having enough trained healthcare workers to manage these tools effectively. 50–70% of clinical decisions depend on accurate laboratory diagnosis, so having reliable diagnostic capabilities is critical.

To address the lack of trained diagnostic workers and laboratory capacity, we opened the Roche Scientific Campus in Johannesburg, South Africa, in 2012. The training centre aims to provide:

• hands-on, certified training courses for lab technologists and engineers,

• general lab management training for managers and policy makers,

• education on health and scientific topics for healthcare professionals and scientists.

The facility boasts ﬁve self-contained laboratories with the latest technological tools in chemistry, haematology, molecular biology, tissue diagnostics and sequencing. Training is conducted by certiﬁed trainers and experts, in collaboration with local and international organisations.

In 2012 Roche and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) formed a ﬁve-year partnership to strengthen training for diagnostics workers in Africa. The goal is to improve laboratory services, including certification courses for pathologists, molecular diagnostics and quality management. The partnership will include collaboration with the African Society for Laboratory Medicine, increasing the sustainability of the partnership.

Microsoft Joins Child Safety Advocates, Law Enforcement for Fourth Global Law Enforcement Training in Paarl, South Africa | ICMEC | SEP 6, 2004

To address the growing problem of children’s safety on the Internet around the world, the International Centre for Missing & Exploited Children, Interpol and Microsoft Corp. continue their series of international training programs for law enforcement personnel who investigate computer-facilitated crimes against children this week in Paarl, Western Cape, South Africa.

The fourth in the series of international law enforcement trainings follows successful sessions held in France, Brazil and Costa Rica earlier this year with more than 300 law enforcement officials representing 100 countries having participated in the training. The International Centre for Missing & Exploited Children plans to conduct eight intensive training programs per year around the world. “Child exploitation online is a complex and increasing social problem,” said Sheila C. Johnson, a board member of the International Centre for Missing & Exploited Children. “To combat global networks of child pornographers, we must all become a global network of child protectors.”

“This type of criminal activity is an international issue transcending borders and jurisdictions,” said John Stamnes, crime intelligence officer at Interpol, who will conduct some of the training. “This course is designed to aid law enforcement all over the world in the development of skills and knowledge necessary to address this type of crime.”

“The use of the Internet to facilitate crimes against children is an increasing problem around the world and one that is best addressed with the collaboration of government, law enforcement and the private sector,” said Pam Portin, director of children’s online child safety at Microsoft. “Microsoft’s role in the training conference is one of many approaches the company is taking to help ensure safety on the Internet. We’re pleased to assist organizations like Interpol and the International Centre in the effort to increase public awareness and expand on the range of technology-based tools available to law enforcement.”

Andre Pienaar | RELATIONSHIP SCIENCE | JAN 8, 2017

International Centre for Missing & Exploited Children | DIRECTOR

Good Governance Group (G3) | Founder

C5 Capital (partnered with Amazon Web Services) | Founder

Kroll | Manager, Africa & Natural Resources Division

BAE Systems | Contractor for BAE through C5 Capital

United States Institute of Peace | Board of Advisors

Africa Union Foundation | Council Member

Convicted of Aiding Adversaries : S. Africa Major a Spy for Black-Ruled State | LOS ANGELES TIMES | MAY 13, 1987

JOHANNESBURG, South Africa — A 32-year-old major in the South African armed forces, accused of spying for at least one of the country’s black-ruled neighbors, was convicted Tuesday in Pretoria of betraying national secrets. Maj. Andre Etienne Pienaar, reputedly a key officer in military intelligence at the Voortrekkerhoogte defense headquarters outside Pretoria, was convicted of three charges under the country’s official secrets act after pleading guilty to some counts but innocent to several others. The indictment is still classified. A South African intelligence expert made payments of as much as £60,000 through his security company for an unregistered charity linked to Dr Liam Fox | THE TELEGRAPH | OCT 22, 2011 Andre Pienaar, a multi-millionaire who keeps out of the public limelight, runs G3 Good Governance Group, a corporate security and intelligence company whose clients include the defence contractor BAE Systems. The chairman of G3’s advisory board is the Duke of Westminster, while the company worked behind the scenes — and free of charge — as security consultants in the run-up to this summer’s royal wedding. As a result, Mr Pienaar, 41, received an invite to the wedding ceremony as a guest of Buckingham Palace. Lt Gen Sir Graeme Lamb, the former director of UK Special Forces, is also listed as a G3 adviser, while Lord Macdonald, the former director of public prosecutions, is a non-executive director of Proven, an investigatory arm of G3. Geoffrey Tantum, a former MI6 Middle East director with wide-ranging connections, is also on the advisory council. Mr Tantum’s daughter, Laura, operates Universal Exports, G3’s charitable foundation which is also the name of the fictional company used as cover by James Bond. Pienaar was previously head of the South African division of Kroll, the world’s biggest risk and security consultancy. G3 has been hugely successful since Mr Pienaar co-founded it in 2004. The company saw its turnover double between 2010 and 2011 from £6 million to £12 million and raised its profits from £1.3 million to £2.4 million — during the period Dr Fox was appointed as Defence Secretary. A source in the security and intelligence business said Mr Pienaar had been keen to help Dr Fox while he was in opposition. “G3 had defence clients but wanted to get more,” said the source. “The deal with Fox was kept quiet even within the company.”

The Clinton Foundation – Delegation Briefing – Africa 2012

Clinton Foundation Donor Brief

Wemos – The Clinical Trials Industry in South Africa: Ethics, Rules and Realities

Clinical_Trials_Industry_South_Africa_2013

Roche – Strengthening Healthcare Infrastructure

Roche_access_to_healthcare

Somo – Examples of Unethical Trials

Examples-of-unethical-trials

Viral Load Access Program | Case-Study_Viral-Load-Access

LANDMARK HIV DIAGNOSTIC ACCESS PROGRAM WILL SAVE $150M AND HELP ACHIEVE NEW GLOBAL GOALS ON HIV | CLINTON FOUNDATION

CHAI announces partnership with governments in six low- and middle-income countries to initiate and expand hepatitis C treatment programs | CLINTON HEALTH ACCESS INITIATIVE

Medical Neocolonialism: Big Pharma Outsources Unethical Clinical Trials To South Africa | MINTPRESS

Pharmaceuticals / Health Products | OPENSECRETS.ORG

Top Recipients, 2015-2016

Candidate Office Amount Clinton, Hillary (D) $2,066,456 Burr, Richard (R-NC) Senate $420,065 Ryan, Paul (R-WI) House $395,174 Portman, Rob (R-OH) Senate $357,940 Paulsen, Erik (R-MN) House $350,750

Nazo Moosa http://archive.is/qQ42P

Nazo Moosa is Managing Partner of v | t partners, which she formed after serving as Managing Partner at C5 Capital, both specialist technology funds. From 2000-2012, she invested in growth capital at the European technology fund of The Carlyle Group, a global alternative asset management company.

News & Guidance: Africa Update | WIKILEAKS PODESTA 34227

From:press@clintonfoundation.org

To: press@clintonfoundation.org

Date: 2015-10-19 21:08

Subject: News & Guidance: Africa Update

“Down a rutted road in Kayonza District, past mud houses and stands of cassava, Eugenie Mujawamariya has gathered her neighbors on a hillside around a fallow field. The soil is the color of milk chocolate and crumbles nicely in the hand. Ms. Mujawamariya explains that she is waiting for prices to rise before sowing her latest bounty of soybeans. Most of her 20 listeners are women wrapped in brightly patterned skirts. They have come to meet the fieldworkers from the Clinton Development Initiative who have been tutoring Ms. Mujawamariya on how to increase yields while also nourishing the land.

“Not unlike agricultural extension agents, the Clinton workers have helped Ms. Mujawamariya grow demonstration plots of soybeans and bananas, varying the spacing, seed varieties, mulching and fertilizer. In one plot, bananas hang from trees in clumps the size of grown men… Ms. Mujawamariya said that her fields now yielded far more than her family could eat, and that her income from sales had doubled. ‘I built a house in the town,’ she said.”

“So when we decided to work in Rwanda on trying to dramatically increase the income of the country and fight the AIDS problem, we wanted to build a healthcare network, because it had been totally destroyed during the genocide in 1994, and the per capita income was still under a dollar a day. So I rang up, asked Paul Farmer if he would help. Because it seemed to me if we could prove there was a model in Haiti and a model in Rwanda that we could then take all over the country, number one, it would be a wonderful thing for a country that has suffered as much as any on Earth in the last 15 years, and number two, we would have something that could then be adapted to any other poor country anywhere in the world. And so we have set about doing that.”

“Let’s take Rwanda. I want to do in these Ebola countries, what we’re trying to do in Rwanda, is build out their health care systems so they don’t need anybody else anymore. You train people and they can run their own system. And we don’t take any money from the American government but the American government started funding this when Hillary was still in office, and they’re training people with 23 American partners, including 10 medical schools, six nursing schools, and all these other people and a bunch of hospitals. They’re doing it all for 7 percent overhead. It’s the least-expensive development project we’ve ever undertaken, which mean people in the audience, their tax dollars go further.”

Headlines | WIKILEAKS PODESTA 57640

From:news@action.clintonfoundation.org

To: john.podesta@gmail.com

Date: 2015-06-19 13:15

Subject: Headlines

John – President Clinton often says, “There can be a big difference between the headlines and the trend lines.” The trend lines show the Clinton Foundation is changing millions of lives.

After the Haiti earthquake, we were one of the first on the ground – and we haven’t left. We’ve raised $36 million to support relief efforts and long-term development and help Haitians generate sustainable economic growth.

We’ve helped provide more than 17 million students with healthier food choices and more physical activity by helping more than 28,000 schools improve their physical and health education programs.

Our energy efficiency programs are reducing more than 33,500 tons of greenhouse gas emissions across the United States each year.

More than 85,000 farmers in Malawi, Rwanda, and Tanzania are benefiting from agricultural training, higher yields, and increased market access.

We are more determined than ever to continue work that’s generating life-changing solutions, but we can’t succeed without you. That’s why we extended our match until midnight tonight to give you another chance to contribute. Every dollar you donate now, up to our $100,000 goal, will be doubled to scale up and replicate successful projects that change lives.

Fwd: MEDIA ADVISORY: President Clinton and Chelsea Clinton to Visit Clinton Foundation Projects in Africa | WIKILEAKS_PODESTA_47022

The Clinton Foundation convenes businesses, governments, NGOs, and individuals to improve global health and wellness, increase opportunity for women and girls, reduce childhood obesity, create economic opportunity and growth, and help communities address the effects of climate change. Because of our work, more than 27,000 American schools are providing kids with healthy food choices in an effort to eradicate childhood obesity; more than 85,000 farmers in Malawi, Rwanda, and Tanzania are benefiting from climate-smart agronomic training, higher yields, and increased market access; more than 33,500 tons of greenhouse gas emissions are being reduced annually across the United States; over 350,000 people have been impacted through market opportunities created by social enterprises in Latin America, the Caribbean, and South Asia; through the independent Clinton Health Access Initiative, 9.9 million people in more than 70 countries have access to CHAI-negotiated prices for HIV/AIDS medications; $200 million in strategic investments have been made, impacting the health of 75 million people in the U.S; and members of the Clinton Global Initiative community have made nearly 3,200 Commitments to Action, which have improved the lives of over 430 million people in more than 180 countries.

Kroll Inc. | WIKIPEDIA

Kroll was founded in 1972 by Jules B. Kroll as a consultant to corporate purchasing departments.[4] The company focused on helping clients improve operations by uncovering kickbacks, fraud or other forms of corruption.

Kroll began its line of investigative work in the financial sector in the 1980s, when corporations in New York City approached Kroll to profile investors, suitors and takeover targets, with special attention to any perceived connections to disreputable organizations, suspicious business practices, personality and integrity issues, or any kind of corporate malfeasance. In the 1990s, Kroll expanded into forensic accounting, background screening, drug testing, electronic data recovery and market intelligence.

In June 1993, A.I.G. “became one of the largest investors in Kroll, after it retained a minority interest in the firm.”[5]

In February 2001, Kroll expanded its working relationship with the insurance company, A.I.G., offering through their Private Client group personal security services to high-net-worth individuals and their families. “Under its working arrangement with AIG, Kroll is called in to supervise crisis management when an incident occurs. In its expanded role the company will now provide those services to private individual holders of AIG policies, providing global protection, for which there is an ever increasing need.”[6]

In 2002, Kroll acquired Kelly McCann‘s firm Crucible. In September 2008, Crucible was acquired by its management and now operates privately.[citation needed] Earlier in 2002, “Kroll’s US corporate advisory subsidiary was given the monumental challenge of restructuring Enron.”[7]

In August 2010, Kroll was acquired by Altegrity, Inc. in an all-cash transaction valued at $1.13 billion. Altegrity’s family of companies also included USIS and Explore. It is principally owned by Providence Equity Partners.[11] Altegrity declared bankruptcy in 2015.

Geographic locations

Kroll is headquartered in New York City, and has offices in Chicago, Philadelphia, Los Angeles, Eden Prairie, Nashville, San Francisco, Dallas, Miami, Loveland and Washington, D.C., as well as Toronto, Ontario, Canada. The Miami office serves as the headquarters for Kroll’s operations in Latin America, where it also has offices in Argentina, Brazil and Mexico.

The Europe, Middle East and Africa (EMEA) region is one of Kroll’s regions. Kroll’s EMEA headquarters are in London, and the company has a presence in Spain, with offices in Madrid and Barcelona. The EMEA region is supported by offices in Paris and Milan, while Kroll’s office in Dubai provides risk consultancy services in the Gulf.

Kroll’s Asian operations are carried out by offices in Hong Kong, Shanghai, Mumbai, Beijing, Singapore and Tokyo.

Ontrack and electronic data recovery

Kroll acquired a computer forensics, electronic discovery, and data recovery company named Ontrack. On January 31, 2006 Kroll Ontrack Inc. announced that it has completed the acquisition of Ibas Holdings ASA, a Norwegian-based provider of data recovery, data erasure and computer forensics services. Ibas became a wholly owned subsidiary of Kroll Ontrack AS, a newly formed Norwegian entity. Prior to its acquisition by Kroll Ontrack Inc., Ibas had expanded its own geographic reach and service offerings through its acquisition of Vogon International, a privately held U.K. company specializing in computer forensics, electronic discovery, and data recovery.[14]

Background screening

Kroll’s Background Screening division provides screening services for areas such as employment, supplier selection, investment placement and institutional admissions. Kroll’s Background Screening division also includes the Kroll Fraud Solutions unit, which specializes in identity theft protection and identity restoration services.[15]

Security consulting

Kroll offers consulting services through Kroll Security Group, its Security Consulting and Security Engineering & Design division. These services include threat assessments, vulnerability assessments, physical security surveys, security disaster planning, policy and procedure development, staffing studies, etc.

Historical cases

The Heroin Trail case

In 1987, in the prominent First Amendment case over The Heroin Trail stories in New York Newsday, attorney Floyd Abrams enlisted Kroll’s help to find an eyewitness: “But was it conceivable that we could come up with an eyewitness who could be of help? I called Jules Kroll, the CEO of Kroll Associates, the nation’s most acclaimed investigative firm, to ask him if he could inquire, through the extensive range of former law enforcement officials employed by him, whether Karaduman was known to be a drug trafficker in Istanbul.”[16] Kroll came through: two weeks into the trial the firm produced Faraculah Arras, who was prepared to testify he was involved in one of Karaduman‘s drug deals. “I was stunned,” recalled Abrams.

Abrams used Kroll again in 1998 to investigate claims by CNN’s Newsstand documentary that sarin nerve gas had been used in Vietnam in 1970 as part of Operation Tailwind.[17]

The John Fredriksen oil theft case

Kroll assisted in the trial of Norwegian shipping tycoon, John Fredriksen, at the end of the 1980s.

WTC and Sears Tower security

Kroll were responsible for revamping security at the World Trade Center after the 1993 World Trade Center bombing.[18][19] They also took on responsibility for security at Chicago’s Sears Tower following the September 11, 2001 attacks.[20] Just prior to the September 11 attacks, Kroll Inc., with the guidance of Jerome Hauer, at the time the Managing director of their Crisis and Consulting Management Group,[12] hired former FBI special investigator John P. O’Neill,[21] who specialized in the Al-Qaeda network held responsible for the 1993 bombing, to head the security at the WTC complex. O’Neill died in the attacks.

Identity protection

[22] As of June 30, 2006, Kroll had over 560,000 customers, according to LegalShield’s quarterly report.[23] In addition to the LegalShield subscribers, Kroll’s Identity Theft Shield serves about 500,000 other consumers. Kroll entered into a joint marketing agreement with legal service plan provider LegalShield (formerly Pre-Paid Legal Services, Inc.) in 2003, to distribute an identity theft product to consumers, called the Identity Theft Shield, the first time Kroll offered a service to individuals.As of June 30, 2006, Kroll had over 560,000 customers, according to LegalShield’s quarterly report.In addition to the LegalShield subscribers, Kroll’s Identity Theft Shield serves about 500,000 other consumers.